Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: PACMA 31
  • Price: $350.0/25mg $750.0/100mg $2250.0/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

1401089-31-3

1401089-31-3 structure
1401089-31-3 structure
  • Name: PACMA31
  • Chemical Name: PACMA 31
  • CAS Number: 1401089-31-3
  • Molecular Formula: C21H22N2O6S
  • Molecular Weight: 430.474
  • Create Date: 2020-01-11 08:07:41
  • Modify Date: 2024-01-10 13:46:16
  • An orally active, irreversible inhibitor of protein disulfide isomerase (PDI), forming a covalent bond with the active site cysteines of PDI; significantly inhibits human ovarian cancer cells OVCAR-8, HEY, and OVCAR-8 growth with IC50 of 0.9, 1.4, and 0.32 uM; significantly suppresses ovarian tumor growth without causing toxicity to normal tissues in mouse xenograft model of human OVCAR-8 ovarian cancer.

Name PACMA 31
Synonyms MFCD26793891
Ethyl N-{[(2,4-dimethoxyphenyl)(propioloyl)amino](2-thienyl)acetyl}glycinate
Glycine, N-[2-[(2,4-dimethoxyphenyl)(1-oxo-2-propyn-1-yl)amino]-2-(2-thienyl)acetyl]-, ethyl ester
PACMA 31
N-(2,4-Dimethoxyphenyl)-N-(1-oxo-2-propyn-1-yl)-2-(2-thienyl)glycyl-glycine ethyl ester
Description An orally active, irreversible inhibitor of protein disulfide isomerase (PDI), forming a covalent bond with the active site cysteines of PDI; significantly inhibits human ovarian cancer cells OVCAR-8, HEY, and OVCAR-8 growth with IC50 of 0.9, 1.4, and 0.32 uM; significantly suppresses ovarian tumor growth without causing toxicity to normal tissues in mouse xenograft model of human OVCAR-8 ovarian cancer.
References References 1. Xu S, et al. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16348-53. 2. Vatolin S, et al. Cancer Res. 2016 Jun 1;76(11):3340-50. View Related Products by Target Protein Disulfide Isomerase (PDI)
Density 1.3±0.1 g/cm3
Molecular Formula C21H22N2O6S
Molecular Weight 430.474
Exact Mass 430.119843
LogP 1.50
Index of Refraction 1.592
Symbol GHS06
GHS06
Signal Word Danger
Hazard Statements H301
Precautionary Statements P301 + P310
RIDADR UN 2811 6.1 / PGIII